Carney complex and teratoma maturum ovarii - a case report

This is a case report of an extremely rare Carney complex (CNC) syndrome in a 17-year-old patient. After the decision made by a team of cancer specialists, the patient was admitted to the hospital for surgery because of adnexal tumor associated with ascites and increased Ca 125 tumor marker level. The patient underwent cardiac surgery twice. Adnexal mass and ascites, revealed by transvaginal ultrasound (TVUS) and confirmed by magnetic resonance imagings (MRI), indicated the malignant alteration. Surgery was performed and surgical pathological staging was refined according to the FIGO guideline and included a staging laparotomy. After surgery, general condition of the patient was good, without ascites and pain, with Ca 125 marker levels within reference ranges.

Carney complex; Teratoma ovarii maturum

[1] Losada Grande E.J., Al Kassam Martinez D., Gonzalez Boillos M.: “Carney complex”. Endocrinol. Nutr., 2011, 58, 308.

[2] Almeida M.Q., Stratakis C.A.: “Best Carney complex and other conditions associated with micronodular adrenal hyperplasia”. Pract. Res. Clin. Endocrinol. Metab., 2010, 24, 907.

[3] Bertherat J., Horvath A., Groussin L., Grabar S., Boikos S., Cazabat L. et al.: “Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes”. J. Clin. Endocrinol. Metab., 2009, 94, 2085.

[4] Kacerovska D., Michal M., Sima R., Grossmann P., Kazakov D.V.: “Carney complex”. Cesk. Patol., 2011, 47, 192.

[5] Peck M.C., Visser B.C., Norton J.A., Pasche L., Katznelson L.: “A novel PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease and the Carney complex”. Endocr. Pract., 2010, 16, 198.

[6] Cazabat L., Ragazzon B., Groussin L., Bertherat J.: “PRKARA1 mutations in primary pigmented nodukar adrenocortical disease”. Pituitary, 2006, 9, 2011.

[7] Mavrakis M., Lippincott-Schwartz J., Stratakis C.A., Bossis I.: “Depletion of type Ia regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency”. Hum. Mol. Genet., 2006, 15, 2962.

[8] Mateus C., Palangiae A., Franck N., Groussin L., Bertagna X., Avril M.F. et al.: “Heterogeneity of skin manifestations in patients with Carney complex”. J. Am. Acad. Dermatology, 2008, 59, 801.

[9] Horvath A., Stratakis C.A.: “Carney complex and lentiginosis”. Pigment Cell Melanoma Res., 2009, 22, 580.

[10] Borkar S.S., Kamath S.G., Kashyap N., Sagar C.V., Rao L., Warrier R., Chauhan A.: “Carney complex report and review”. J. Cardiothor. Surg., 2011, 5, 25.

[11] Stratakis C.A., Papageorgiou T., Premkumar A., Pack S., Kirschner L.S., Taymans S.E. et al.: “Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy”. J. Clin. Endocrinol. Metabol., 2000; 85(11):4359.

[12] Carney J.A., Stratakis C.A.: “Virilizing ovarian stromal tumor in a young woman with Carney complex”. Am. J. Surg. Pathol., 2011, 35, 1592.

[13] Papageorgiou T., Stratakis C.A.: “Ovarian tumors associated with multiple endocrine neoplasias and related syndromes Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowdens disease”. Int. J. Gynecol. Cancer, 2002, 12, 337.

[14] Lytras A., Tolis G.: “Reproductive disturbances in multiple neuroendocrine tumor syndromes”. Endocr. Relat. Cancer, 2009, 6, 1125.

[15] Kirschner L.S.: “Use of mouse models to understand the molecular basis of tissue- specific tumoriogenesis in the Carney complex”. J. Intern. Med., 2009, 266, 60.

[16] Bertherat J.: “Carney complex (CNC)”. Orphanet. J. Rare Dis., 2006, 21.

[17] Halaszlaki C., Takacs I., Patocs A., Lakatos P.: “Novel mutation in patient with Carney complex”. Orv. Hetil., 2011, 152, 802.

[18] Shetty Roy A.N., Radin M., Sarabi D., Shaoulian E.: “Familial recurrent atrial myxoma: Carney complex”. Clin. Cardiology, 2011, 34, 83.

[19] Jabbour S.A., Davidovici B.B., Wolf R.: “Rare syndromes”. Clin. Dermat., 2006, 24, 299.